View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

U.S. Cyber Command Issues Parsons’ Subsidiary Intent to Award for Join...

U.S. Cyber Command Issues Parsons’ Subsidiary Intent to Award for Joint Cyber Hunt Kit (JCHK) Production SealingTech, a Parsons company, was competitively selected for the $500 million contract CHANTILLY, Va., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Sealing Technologies (SealingTech), a Parsons Corporation company (NYSE: PSN), and leading defensive cyber operations solution provider, received an Intent to Award notification from the United States Cyber Command (USCYBERCOM) for a sole-source contract to begin production on the company’s Joint Cyber Hunt Kit solution. The three-year period of p...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Martin Midstream Partners L.P. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 6 February 2026 in which we reassessed the appropriateness of the ratings in...

David Nierengarten ... (+8)
  • David Nierengarten
  • Dennis Pak
  • Geoffrey Von Der Ahe
  • Laura Chico
  • Martin Fan
  • Robert Driscoll
  • Thomas Yip
  • Yun Zhong
 PRESS RELEASE

Parsons to Present at the Barclays 43rd Annual Industrial Select Confe...

Parsons to Present at the Barclays 43rd Annual Industrial Select Conference CHANTILLY, Va., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial officer, will participate in a fireside chat question and answer session at the Barclays 43rd Annual Industrial Select Conference on Wednesday, February 18, 2026, at approximately 3:35 p.m. Eastern Time. The presentation will be available live via webcast on the investor relations section of Parsons’ website (). A replay...

 PRESS RELEASE

OPKO Health to Report Fourth Quarter 2025 Financial Results on Februar...

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 2026. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-r...

 PRESS RELEASE

Parsons Reports Fourth Quarter and Fiscal Year 2025

Parsons Reports Fourth Quarter and Fiscal Year 2025 Q4 2025 Financial Highlights  Q4 revenue of $1.6 billion decreased 8% year-over-year and 10% on an organic basisTotal revenue growth of 11% and 8% on an organic basis excluding confidential contractNet income of $56 million increased 3% year-over-year, a fourth quarter recordRecord adjusted EBITDA of $153 million increased 5%; adjusted EBITDA margin of 9.6%Cash flow from operations increased 32% to $168 millionBook-to-bill ratio of 0.9x and continued streak of TTM book-to-bill ratio of 1.0x or greater in every quarter since IPO Fiscal Ye...

 PRESS RELEASE

Parsons Awarded $125M Contract to Support the U.S. Army Combat Capabil...

Parsons Awarded $125M Contract to Support the U.S. Army Combat Capabilities Development Command Army Research Laboratory CHANTILLY, Va., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) has been awarded a $125 million single-award Task Order contract over five years to support the U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL), High Performance Computing Modernization Program (HPCMP), and Defense Research and Engineering Network (DREN). This recompeted award highlights Parsons’ commitment to advancing research and development in ...

 PRESS RELEASE

Parsons Secures $91 Million Contract Extension for U.S. Diplomatic Mis...

Parsons Secures $91 Million Contract Extension for U.S. Diplomatic Mission Security Worldwide CHANTILLY, Va., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced the company secured a $91 million contract extension for the Overseas Security Installation Services (OSIS II) contract administered by the U.S. Department of State. This is the seventh option year award of a 10-year contract, and part of the broader nearly $1.12 billion OSIS II contract. The extension underscores Parsons’ consistent performance and long-standing reputation as a reliable partner in deliver...

Yun Zhong
  • Yun Zhong

Good Progress On Afrezza Towards 5/29/2026 PDUFA

Figure 1 - Original Dose Conversion TableSource: FDAFigure 2 - Updated Dose Conversion TableSource: Company dataFigure 3 - Updated Starting Dose Reduces Postprandial Peak GlucoseSource: Company data

 PRESS RELEASE

Noodles & Company Announces Plans For 1-for-8 Reverse Stock Split Effe...

Noodles & Company Announces Plans For 1-for-8 Reverse Stock Split Effective February 18, 2026 BROOMFIELD, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq: NDLS) announced today that it plans to effect a 1-for-8 reverse stock split ("Reverse Stock Split") of its Class A common stock, par value $0.01 per share ("Common Stock"), that is expected to become effective on February 18, 2026 at 12:01 a.m.. Eastern Time. Noodles’ Common Stock will continue to trade on The Nasdaq Global Select Market (“Nasdaq”) under the existing symbol “NDLS” and is expected to begin trading on ...

 PRESS RELEASE

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Clas...

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase 1 data from injectable oxyntomodulin (OXM) expected in late 2026; o...

 PRESS RELEASE

Parsons’ C-UAS DroneArmor™ Deployed to Protect U.S. Border and Nationa...

Parsons’ C-UAS DroneArmor™ Deployed to Protect U.S. Border and National Security CHANTILLY, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that DroneArmor™, the company’s counter-unmanned aircraft system (C-UAS), has been deployed by a Federal national security customer to enhance security and protect personnel, communities, and critical infrastructure along the United States southern border. The proven, military-grade command and control (C2) system is purpose-built to provide streamlined and autonomous C-UAS protection. DroneArmor™, a Technology ...

 PRESS RELEASE

Parsons Awarded $60 Million Contract To Design Claremont Extension Of ...

Parsons Awarded $60 Million Contract To Design Claremont Extension Of Los Angeles’s Metro A Line Light Rail System CHANTILLY, Va., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that it has been awarded a six-year, $60 million new contract by the Foothill Gold Line Construction Authority to complete design of phase 2B2 of the Foothill Gold Line project and provide design services during construction. As part of the longest linear light rail line in the world, phase 2B2 will complete the next segment of the Metro A Line light rail system, by adding a 2.3-...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 30, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 29, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Parsons Awarded $593 Million Federal Aviation Administration Contract ...

Parsons Awarded $593 Million Federal Aviation Administration Contract Extension Early option exercise underscores Parsons’ critical role in FAA’s nationwide airspace modernization CHANTILLY, Va., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a $593 million contract extension under the Federal Aviation Administration’s (FAA) Technical Support Services Contract 5 (TSSC 5). TSSC 5 has a $1.8 billion ceiling value with a four-year base period and two three-year option periods. This award exercises the first option period, exte...

 PRESS RELEASE

Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.16 per S...

Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.16 per Share ANCHORAGE, Alaska, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.16 per share. The dividend will be payable on March 13, 2026, to shareholders of record at the close of business on March 5, 2026. “We are pleased to announce a quarterly dividend of $0.16 per share, as we continue to provide returns to our shareholders,” said Mike Huston, President and CEO. At the stock price of $25.25 per share at ...

 PRESS RELEASE

Northrim BanCorp Earns $12.4 Million, or $0.55 Per Diluted Share, in F...

Northrim BanCorp Earns $12.4 Million, or $0.55 Per Diluted Share, in Fourth Quarter 2025, and $64.6 Million, or $2.87 Per Diluted Share, for the Year Ended December 31, 2025 ANCHORAGE, Alaska, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $12.4 million, or $0.55 per diluted share, in the fourth quarter of 2025, compared to $27.1 million, or $1.20 per diluted share, in the third quarter of 2025, and $10.9 million, or $0.49 per diluted share, in the fourth quarter a year ago. The decrease in the fourth quart...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch